180 related articles for article (PubMed ID: 16427438)
1. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
3. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
5. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Da Fonseca CO; Silva JT; Lins IR; Simão M; Arnobio A; Futuro D; Quirico-Santos T
Invest New Drugs; 2009 Dec; 27(6):557-64. PubMed ID: 19139816
[TBL] [Abstract][Full Text] [Related]
6. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
8. Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.
Chen TC; Da Fonseca CO; Schönthal AH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598140
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
11. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
12. Cell surface receptors in malignant glioma.
Li YM; Hall WA
Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
[TBL] [Abstract][Full Text] [Related]
13. Perillyl alcohol as a radio-/chemosensitizer in malignant glioma.
Rajesh D; Stenzel RA; Howard SP
J Biol Chem; 2003 Sep; 278(38):35968-78. PubMed ID: 12805388
[TBL] [Abstract][Full Text] [Related]
14. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
Da Fonseca CO; Masini M; Futuro D; Caetano R; Gattass CR; Quirico-Santos T
Surg Neurol; 2006 Dec; 66(6):611-5. PubMed ID: 17145324
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeted therapies and chemotherapy in malignant gliomas.
Brandsma D; van den Bent MJ
Curr Opin Oncol; 2007 Nov; 19(6):598-605. PubMed ID: 17906459
[TBL] [Abstract][Full Text] [Related]
17. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for malignant glioma.
Mason WP
Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
[TBL] [Abstract][Full Text] [Related]
19. Incorporating molecular tools into clinical trials and treatment for gliomas?
Lassman AB; Holland EC
Curr Opin Neurol; 2007 Dec; 20(6):708-11. PubMed ID: 17992094
[TBL] [Abstract][Full Text] [Related]
20. New molecular targets in malignant gliomas.
de Groot JF; Gilbert MR
Curr Opin Neurol; 2007 Dec; 20(6):712-8. PubMed ID: 17992095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
